Investigational Site Number :7240004

Madrid, Madrid, Comunidad de 28050

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Cutaneous Lupus Erythematosus, Neoplasm, Non-small Cell Lung Cancer, Pleural Mesothelioma

Studies at this site

• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — Stopped early
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus — Completed
• Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies — Stopped early